{"Title": "Liver : The gut is a key target of therapy in hepatic encephalopathy", "Year": 2015, "Source": "Nat. Rev. Gastroenterol. Hepatol.", "Volume": "12", "Issue": 1, "Art.No": null, "PageStart": 7, "PageEnd": 8, "CitedBy": 4, "DOI": "10.1038/nrgastro.2014.185", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84926198374&origin=inward", "Abstract": "\u00a9 2015 Macmillan Publishers Limited.Little progress has been made in the pharmacological management of patients with hepatic encephalopathy, partly because it is difficult to perform clinical trials in this group of patients. A new clinical trial now suggests that polyethylene glycol is more effective than the current standard first-line therapy in these patients.", "AuthorKeywords": null, "IndexKeywords": ["Gastrointestinal Agents", "Hepatic Encephalopathy", "Humans", "Intestines", "Lactulose", "Polyethylene Glycols", "Rifamycins", "Treatment Outcome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-84926198374", "SubjectAreas": [["Hepatology", "MEDI", "2721"], ["Gastroenterology", "MEDI", "2715"]], "AuthorData": {"56425524700": {"Name": "Sawhney R.", "AuthorID": "56425524700", "AffiliationID": "60022148, 60032819", "AffiliationName": "Institute for Liver and Digestive Health, University College London, Royal Free Hospital"}, "7005505892": {"Name": "Jalan R.", "AuthorID": "7005505892", "AffiliationID": "60022148, 60032819", "AffiliationName": "Institute for Liver and Digestive Health, University College London, Royal Free Hospital"}}}